NKTR : Analysis & Opinions
October 9, 2012New York, May 23rd (TradersHuddle.com) - These are the research analyst new ratings before the market open. Travelers (NYSE:TRV) ...
January 18, 2012Salix is a great candidate for growth investors.
December 15, 2010MannKind is a classic high-risk high-reward biotech story.
June 22, 2010Clinical failure is not the end of the story for all biotechs. How do some survive while others disappear?